Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Farmacia
versión impresa ISSN 0034-7515versión On-line ISSN 1561-2988
Resumen
ARBESU MICHELENA, María Antonieta; RAMOS FERNANDEZ, Maritza; FERNANDEZ ARGUELLES, Rogelio y PLANCHE AGUILAR, Laritza. Information on presence of antimicrobial agents in a cohort of health professionals in Oncology Institute. Rev Cubana Farm [online]. 2009, vol.43, n.2. ISSN 0034-7515.
Success of an antimicrobial treatment is influenced by several objective and subjective factors that in different reports from Pharmacy and Therapeutics Committee of National Institute of Oncology and Radiology during 2006, problems related to fulfillment of antibiotics policy were described which has been justified by affected persons due to impossibility to use microbiology techniques. In the same way, these professionals propose that "antimicrobial policy is incorrect by lack of updated microbiologic map"; however, it is unknown existence of other factors, like the information of each professional to prescribe a therapy that may influence in the result of antimicrobial use. To determine where does the knowledges acquired are reminded in professional training of staff selected, from pregraduate literature, related to therapeutics and that may or not to influence in antimicrobial prescription it was possible to perform present study. Authors designed a 5 questions survey with a multiple option and four options to mark only one as correct and it was validated by experts, which was applied to physicians and Pharmacy technicians. Results achieved showed a certain degree of forgetting of some significant concepts that may to influence in a negative way on success of anti-infectious therapy in oncologic patients, mainly those candidates for surgery as oncospecific treatment, thus, we recommend to Teaching Management the performing of updates for institution staff.
Palabras clave : Antimicrobials; antimicrobial prophylaxis; antimicrobial combination; maximal dose; pharmaceutical interactions.